-The Economic Times Rajan Mittal resigned as director of Bharti Retail last November, barely weeks after the Enforcement Directorate launched a probe into a controversial $100-million investment by Walmart Stores in Cedar Support Services, the holding company of the retail venture. A Bharti spokesman said Mittal had resigned from the board last year to "take out time for his other commitments" and has been replaced by Bharti Group's general counsel and...

-The Indian Express Chandigarh: Call it fear of social ostracism, or lack of belief in law and order machinery, more and more reports of sexual assault victims trying to kill self are coming to light in Haryana. In the last four months, at least six such cases have been reported where the victims of sexual harassment, including molestation, stalking and rape, have attempted suicide. In the most recent incident, a Karnal based woman...

-The Economic Times The BT cotton revolution, which swept India's countryside, is now doubling up as the source of the country's cheapest cooking oil. And in Narendra Modi's motherland, the Jasubens are loving it. Cottonseed or 'kapasiya' oil is ruling in the kitchens of Gujarat, the largest cotton-growing state. One out of every two bottles of oil consumed in Gujarat contains cottonseed oil. "Earlier, we used around three litres of cottonseed oil...

-The Hindu     Enhancing the basket of contraceptive choices can reduce maternal mortality rate, says a family planning review Family planning has made a silent comeback in the national discourses. This time, focussing more on concomitant improvement in the health of the people rather than limiting the number of children. India had changed its strategy on family planning in 2010 with the other developing countries from that of merely reducing population to that of...

-The Hindu The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness On April 1, 2013, the Supreme Court upheld the Intellectual Property Appellate Board's decision to deny patent protection to Novartis's application covering a beta crystalline form of imatinib -the medicine Novartis brands as Glivec, and which is very effective against the form of cancer known as chronic myeloid leukaemia (CML). The...